• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • eedwards@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
  • DONATE
JOIN or RENEW HERE
✕
Categories
  • Nonalcoholic Steatohepatitis
Tags
  • Nonalcoholic Steatohepatitis (NASH)

 

Study title A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) (Harmony)
Disease or condition NASH-Nonalcoholic Steatohepatitis
Study type Interventional  (Clinical Trial)
Intervention/treatment Efruxifermin or Placebo
Phase 2b
Study site Carolinas Medical Center, Center for Transplant and Liver Care (Atrium Health)
Study location Charlotte, NC
Principal investigator name and email Andrew deLemos, andrew.delemos@atriumhealth.org
Study coordinator name and email Caitlyn Delgado, caitlyn.delgado@atriumhealth.org
Phone Contact 704-446-4834
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04767529

ADDRESS


801 E Morehead Street
Suite 110
Charlotte NC 28202

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


eedwards@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE